Sallie B. Cosgrove

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the<scp>J</scp>anus kinase inhibitor oclacitinib (<scp>A</scp>poquel^®) in client‐owned dogs with atopic dermatitis

Sallie B. Cosgrove, J. A. WREN, Dawn M. Cleaver et al. · Veterinary Dermatology · 2013 · 140 citations · Full text

Medicine, Dermatology, Pharmacology +11

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

Sallie B. Cosgrove, J. A. WREN, Dawn M. Cleaver et al. · Veterinary Dermatology · 2013 · 130 citations · Full text

Medicine, Pharmacology, Veterinary Dermatology +14

Long‐term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life

Sallie B. Cosgrove, Dawn M. Cleaver, Vickie L. King et al. · Veterinary Dermatology · 2015 · 99 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client‐owned dogs

Peter R. Little, Vickie L. King, Kylie R. Davis et al. · Veterinary Dermatology · 2014 · 96 citations · Full text

Medicine, Dermatology, Veterinary Dermatology +15

TREATMENT SUCCESS IN THREE ANDEAN BEARS (<i>TREMARCTOS ORNATUS</i>) WITH ALOPECIA SYNDROME USING OCLACITINIB MALEATE (APOQUEL®)

Gabby Drake, Tim Nuttall, Javier López et al. · Journal of Zoo and Wildlife Medicine · 2017 · 40 citations

Medicine, Dermatology, Immunology +16